Mount Sinai Researchers Advance a Universal Influenza Virus Vaccine
December 09, 2020
December 09, 2020
NEW YORK, Dec. 9 (TNSRes) -- he Icahn School of Medicine at Mount Sinai issued the following news release on Dec. 7:
A vaccine that induces immune responses to a wide spectrum of influenza virus strains and subtypes has produced strong and durable results in early-stage clinical trials in humans, Mount Sinai researchers have found. The universal influenza virus vaccine, which produces antibodies that target the part of the surface protein of the influenza virus known to neutralize d . . .
A vaccine that induces immune responses to a wide spectrum of influenza virus strains and subtypes has produced strong and durable results in early-stage clinical trials in humans, Mount Sinai researchers have found. The universal influenza virus vaccine, which produces antibodies that target the part of the surface protein of the influenza virus known to neutralize d . . .